Janux Therapeutics

+$0.16 (+1.23%) As of 1:35 PM UTC today

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell JANX and other ETFs, options, and stocks.

About JANX

Janux Therapeutics, Inc. operates preclinical stage biopharmaceutical company which engages in developing therapeutics based on the Tumor Activated T Cell Engager platform technology. The company was founded in June 2017 and is headquartered in La Jolla, CA.

CEO
David Campbell
Employees
33
Headquarters
La Jolla, California
Founded
2017

JANX Key Statistics

Market cap
549.51M
Price-Earnings ratio
—
Dividend yield
—
Average volume
150.05K
High today
$13.20
Low today
$13.20
Open price
$13.20
Volume
130.00
52 Week high
$35.93
52 Week low
$9.39

JANX Earnings

-$0.62
-$0.41
-$0.21
$0.00
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Estimated
— per share
Actual
Expected Aug 9, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure